Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011554

President sold 30,000 shares at an average $65.61 ($1,968,432)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-12 Exercise or conversion : show line 1 in the form +15,000 $6.55 $98,250 15,000 D
2021-02-12 Sale : show line 2 in the form −1,949 $64.53 $125,769 13,050 D
2021-02-12 Sale : show line 3 in the form −3,130 $65.55 $205,172 9,921 D
2021-02-12 Sale : show line 4 in the form −9,621 $66.38 $638,642 300 D
2021-02-12 Sale : show line 5 in the form −300 $67.00 $20,100 0 D
2021-02-16 Exercise or conversion : show line 6 in the form +15,000 $6.55 $98,250 15,000 D
2021-02-16 Sale : show line 7 in the form −1,699 $64.78 $110,061 13,301 D
2021-02-16 Sale : show line 8 in the form −13,301 $65.31 $868,688 0 D
Open-market sales · 30,000 sh · avg $65.61 · $1,968,432

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-12 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −15,000 345,000 D
2021-02-16 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −15,000 330,000 D
Loading xslF345X03/doc4.xml…